Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Market Closed - Nyse
Other stock markets
 04:30:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
1.45 USD +5.84% Intraday chart for NKGen Biotech, Inc. -13.17% -82.53%
Jun. 03 NKGen Biotech, Inc. To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 CI
May. 23 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting CI
74303b13585ba0a40c77db4ccc4af0._Q9jj-psk2-4faGS5PcF92JsAg_zAAa75vJVjQ_u4Ug.ilUvxrhU-B_bG8jc3KBq2gc7XT_KZWzyqZYS5j2tqTuXXw65jybeDe8i0g~28fad41ae69b939dd4328c8427b79946
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. Charts NKGen Biotech, Inc.
  6. News Chart